1 Versus 2 Hours Post Meal Glucose Monitoring in Gestational Diabetes on Treatment
NCT ID: NCT05326204
Last Updated: 2025-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2954 participants
OBSERVATIONAL
2021-12-30
2025-12-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
4 vs 7 Points Blood Glucose Monitoring in Gestational Diabetes on Dietary Modification
NCT04101396
Glucose Testing in GDM: Adherence to One- Versus Two-hour Postprandial Glucose Monitoring in Gestational Diabetics
NCT05062460
Effect of Low Glycemic Index on Gestational Diabetes Mellitus
NCT03801824
Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy
NCT05430204
The Effect of Continuous Glucose Monitoring on Glycemic Control in Insulin-requiring Gestational Diabetes Mellitus
NCT02204657
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 hour
Blood glucose monitoring comprises of 1 hour post meal
Home blood glucose monitoring
Self monitoring of capillary blood glucose
2 hours
Blood glucose monitoring comprises of 2 hours post meal
Home blood glucose monitoring
Self monitoring of capillary blood glucose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home blood glucose monitoring
Self monitoring of capillary blood glucose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* requiring treatment either with metformin alone or combined with insulin
Exclusion Criteria
* bad obstetrics history
* underlying medical disorders such as Systemic Lupus Erythematosus
* fetal anomaly
* delivery elsewhere
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National University of Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rahana Abd Rahman
Role: PRINCIPAL_INVESTIGATOR
National University of Malaysia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UKM Medical Center
Kuala Lumpur, W.Persekutuan, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FF-2022-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.